Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Expression of the CagA gene ofH. pylori and application of its product.

Literature DB >> 11819538

Expression of the CagA gene ofH. pylori and application of its product.

Feng-Chan Han, Xiao-Jun Yan, Cheng-Zhi Su.

Abstract

Entities: Gene

Year: 2000 PMID： 11819538 PMCID： PMC4723578 DOI： 10.3748/wjg.v6.i1.122

Source DB: PubMed Journal: World J Gastroenterol ISSN： 1007-9327 Impact factor: 5.742

× No keyword cloud information.

9 in total

1. IgG immune response to Helicobacter pylori antigens in patients with gastric cancer as defined by ELISA and immunoblotting.

Authors: K Klaamas; M Held; T Wadström; A Lipping; O Kurtenkov
Journal: Int J Cancer Date: 1996-07-03 Impact factor: 7.396

2. A model of protein-colloidal gold interactions.

Authors: C De Roe; P J Courtoy; P Baudhuin
Journal: J Histochem Cytochem Date: 1987-11 Impact factor: 2.479

3. Simplified purification and testing of colloidal gold probes.

Authors: B L Wang; L Scopsi; M Hartvig Nielsen; L I Larsson
Journal: Histochemistry Date: 1985

4. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology.

Authors: J E Crabtree; J D Taylor; J I Wyatt; R V Heatley; T M Shallcross; D S Tompkins; B J Rathbone
Journal: Lancet Date: 1991-08-10 Impact factor: 79.321

5. Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production.

Authors: M K Tummuru; T L Cover; M J Blaser
Journal: Infect Immun Date: 1993-05 Impact factor: 3.441

6. Prevalence of CagA-bearing Helicobacter pylori strains detected by the anti-CagA assay in patients with peptic ulcer disease and in controls.

Authors: C K Ching; B C Wong; E Kwok; L Ong; A Covacci; S K Lam
Journal: Am J Gastroenterol Date: 1996-05 Impact factor: 10.864

7. Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer.

Authors: J E Crabtree; J I Wyatt; G M Sobala; G Miller; D S Tompkins; J N Primrose; A G Morgan
Journal: Gut Date: 1993-10 Impact factor: 23.059

8. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer.

Authors: A Covacci; S Censini; M Bugnoli; R Petracca; D Burroni; G Macchia; A Massone; E Papini; Z Xiang; N Figura
Journal: Proc Natl Acad Sci U S A Date: 1993-06-15 Impact factor: 11.205

9. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach.

Authors: M J Blaser; G I Perez-Perez; H Kleanthous; T L Cover; R M Peek; P H Chyou; G N Stemmermann; A Nomura
Journal: Cancer Res Date: 1995-05-15 Impact factor: 12.701

9 in total

8 in total

1. Supra-angular biopsy is more reliable for atrophy recognization: analysis of 1598 cases for gastric mucosal histological examination.

Authors: Ya-Li Zhang; Zhuo-Sheng Lai; Dian-Yuan Zhou; Nobutaka Yamada; Min Wen
Journal: World J Gastroenterol Date: 2000-12 Impact factor: 5.742

2. Study of T-lymphocyte subsets, nitric oxide, hexosamine and Helicobacter pylori infection in patients with chronic gastric diseases.

Authors: Hui Zhang; Shu-Lin Jiang; Xi-Xian Yao
Journal: World J Gastroenterol Date: 2000-08 Impact factor: 5.742

Expression of the CagA gene ofH. pylori and application of its product.

1. IgG immune response to Helicobacter pylori antigens in patients with gastric cancer as defined by ELISA and immunoblotting.

2. A model of protein-colloidal gold interactions.

3. Simplified purification and testing of colloidal gold probes.

4. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology.

5. Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production.

6. Prevalence of CagA-bearing Helicobacter pylori strains detected by the anti-CagA assay in patients with peptic ulcer disease and in controls.

7. Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer.

8. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer.

9. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach.

1. Supra-angular biopsy is more reliable for atrophy recognization: analysis of 1598 cases for gastric mucosal histological examination.

2. Study of T-lymphocyte subsets, nitric oxide, hexosamine and Helicobacter pylori infection in patients with chronic gastric diseases.

Review 3. Current gene therapy for stomach carcinoma.

4. L-forms of H. pylori.

5. Detection of H. pylori antibody profile in serum by protein array.

6. Intravenous chemotherapy for resected gastric cancer: meta-analysis of randomized controlled trials.

7. Detection of serum anti-Helicobacter pylori immunoglobulin G in patients with different digestive malignant tumors.

8. Construction, Cloning, and Expression of CagA Recombinant Protein of Helicobacter pylori.